Moneycontrol PRO
Upcoming Webinar:Watch Kushal Bhagi of Tortuga Wealth Managers decode how you can maximise your MF investments on Sept 21 @11am. Register Now

Cresting 'first wave' of stimulus may be next hurdle for world markets

The US Federal Reserve, European Central Bank, Bank of England, and Bank of Japan joined others in March with a wave of stimulus to stem damage from the coronavirus pandemic.

July 16, 2020 / 10:31 PM IST

A growth spurt in the balance sheets of the world's biggest central banks has crested in recent weeks, drawing warnings from investors that any signs of backpedaling on stimulus will jolt financial markets and strangle economic recovery.

The US Federal Reserve, European Central Bank, Bank of England, and Bank of Japan joined others in March with a wave of stimulus to stem damage from the coronavirus pandemic.

Their combined balance sheets grew by an estimated $5.3 trillion as they expanded quantitative easing programmes via asset purchases, which - hitherto restricted largely to government bonds - now include a wider remit, spanning equities to junk corporate debt.

But as markets have rebounded and economies reopen, that balance sheet surge is levelling off.

Reuters analysis found growth in the four central banks' balance sheets slowed for the second straight month in June, with some $852 billion added. That was less than half of what was added in April.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"Now that market functioning has largely normalized, central banks are actually reducing their support measures," BofA rates strategist Ralf Preusser told clients.

Authorities are no longer in fire-fighting mode as they were during the March-April meltdown. Yet, the slowdown is significant.

First, a resurgence of coronavirus infections worldwide is forcing authorities to reimpose lockdowns, dashing hopes of swift economic recovery.

Second, emergency government schemes, such as worker furloughs and benefits supplements, are also due to expire.

That's rekindled fears of a "taper tantrum", similar to the market panic which ensued in 2013 when the Fed hinted at unwinding stimulus.

"The recovery is actually at risk from insufficient fiscal efforts, and central banks will turn more, not less, aggressive," Preusser added.


Evidence of stimulus deceleration is widespread. The BOE has halved its rate of gilt purchases and cited some signs of economic recovery, while the Reserve Bank of Australia has not purchased any assets since early-May.

The BOJ this week effectively suggested a pause in monetary easing.

And at the ECB, weekly bond purchases under the Pandemic Emergency Purchase Programme (PEPP) fell to 17.5 billion euros last week, the slowest since its start in March.

Danske Bank chief strategist Piet Haines Christiansen estimates the ECB is buying at a rate of about 4 billion euros a day. At that pace, he reckons the ECB could hit the PEPP's 1.35 trillion-euro limit by next June.

But various ECB policymakers have indicated that limit may not be fully utilized. That would mean a substantial decline in purchases, Christiansen says.

"Markets do not appreciate that yet," he warned. "Markets expect full PEPP implementation so if purchases are scaled back well below the 4 billion euros a day, we may see a reaction in markets."

It's not all bad news - bond markets were reassured on Thursday by ECB President Christine Lagarde who said the PEPP facility would be fully utilised.

Meanwhile, the Fed balance sheet shrinkage is mostly down to reduced demand for its swap and repo facilities as global dollar shortages eased.


The looming expiry of US and European worker support schemes, however, remains a concern, said Jim Leaviss, head of fixed income at M&G Investments.

"The second half (of 2020) will be all about the new taper tantrum," Leaviss added.

First up is the end-July expiration of a $600 weekly supplement for unemployed Americans -- dubbed the "benefits cliff" by Deutsche Bank, which sees this as one of the defining moments for markets this summer.

Asset manager BlackRock cited that cliff as a reason to cut US equities in favour of Europe, where a ground-breaking recovery fund is under debate to aid hardest-hit states.

But worker furloughs start winding down across Europe too this autumn, including in Britain, Spain and Netherlands.

IMF Managing Director Kristalina Georgieva warned on Wednesday it was premature to start withdrawing safety nets, while Lagarde said the cliff needed monitoring.

Ultimately though the prospect of market tantrums may be what deters authorities from hitting the brakes too hard.

Daniel White, senior research and strategy manager at Canada Life Investments, said the sheer scale of stimulus meant some tapering was inevitable, but authorities would tread carefully.

"The story of the past 15 years is that governments and central banks have become hostages (of markets)," White said.

BofA predicts balance sheet expansion to resume too; its analysis shows every major central bank will end 2020 with a bigger balance sheet than now.


stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark